New drug combo aims to tame Cushing's disease with fewer side effects
NCT ID NCT07603466
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding cabergoline to osilodrostat works better than osilodrostat alone for controlling Cushing's disease. About 50 adults with active Cushing's disease will receive either the combination or the single drug. The goal is to see if the combo can lower cortisol faster, reduce the needed dose of osilodrostat, and lessen side effects like high blood pressure and hormone imbalances.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUSHING DISEASE DUE TO INCREASED ACTH SECRETION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Al-Hassan Metabolism Endocrine and Diabetes Center
Karbala, Iraq
-
Al-Waffa Specialized Center for Diabetes and Endocrinology
Mosul, Iraq
-
Faiha Specialized Diabetes, Endocrine, and Metabolism Center
Basra, 61001, Iraq
-
Najaf Specialized Diabetes and Endocrine Center
Najaf, Iraq
-
Thi-Qar Specialized Diabetes, Endocrine and Metabolism Center
Nasiriyah, Iraq